Summary by Moomoo AI
Pharmaceutical United Biotechnology Co., Ltd. (WuXi XDC Cayman Inc.) , share code 02268, filed an updated monthly statement of changes in securities with Hong Kong Trading and Settlement Limited on 6 May 2024. The report shows that as of April 30, 2024, the company's regulated/registered share capital remained at 10,000,000,000 shares with a face value of $0.00005 per share for a total of $500,000, unchanged this month. In addition, under the Company's stock option plan, including the 2021 and 2023 Initial Public Offering Share Option Plans, no new shares were issued during this month as a result of the exercise of share options and no share rights were granted on or after the listing date. The Executive Director, Chief Financial Officer and Company Secretary Shi Xiaojie confirmed that all securities issuance has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.